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The aim of this study was to reveal the molecular mechanism involved in multidrug
resistance and virulence of Campylobacter jejuni isolated from broiler chickens. The
virulence of six multidrug resistant C. jejuni was determined by in vitro and in vivo
methods. The de novo whole genome sequencing technology and molecular biology
methods were used to analyze the genomic features associated with the multidrug
resistance and virulence of a selected isolate (C. jejuni 1655). The comparative genomic
analyses revealed a large number of single nucleotide polymorphisms, deletions,
rearrangements, and inversions in C. jejuni 1655 compared to reference C. jejuni
genomes. The co-emergence of Thr-86-Ile mutation in gyrA gene, A2075G mutation
in 23S rRNA gene, tetO, aphA and aadE genes and pTet plasmid in C. jejuni 1655
contributed its multidrug resistance to fluoroquinolones, macrolides, tetracycline, and
aminoglycosides. The combination of multiple virulence genes may work together to
confer the relative higher virulence in C. jejuni 1655. The co-existence of mobile gene
elements (e.g., pTet) and CRISPR-Cas system inC. jejuni 1655may play an important role
in the gene transfer and immune defense. The present study provides basic information
of phenotypic and genomic features of C. jejuni 1655, a strain recently isolated from a
chicken displaying multidrug resistance and relatively high level of virulence.
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INTRODUCTION
Campylobacter jejuni is one of the most important foodborne pathogens worldwide (Abril et al.,
2010). The macrolides (mainly erythromycin and azithromycin) and fluoroquinolones are the
empirical drugs of choice for treatment of campylobacteriosis (Allos, 2001). Other antimicrobial
agents, including gentamicin, meropenem, and clindamycin are alternative therapies (Iovine et al.,
2008).
The National Antimicrobial Resistance Monitoring System (NARMS) in the USA and Danish
Integrated Antimicrobial Resistance Monitoring and Research Program (DANMAP) data showed
that multidrug resistance in C. jejuni has been very rare (0.3-0.7%) from retail chicken meat
(DANMAP, 2014; NARMS, 2015). Multidrug resistant C. jejuni have been isolated from chicken
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farms in China recently (Chen et al., 2010; Hao et al., 2015; Wang
et al., 2016). The multidrug resistant C. jejuni in chicken may
greatly threaten food safety and human public health, therefore it
is important to investigate the virulence potential andmechanism
involved in multidrug resistance and virulence of C. jejuni.
Although genomes of many human-source C. jejuni (e.g.,
NCTC11168, 81–176, 260.94, HB93-13, CF93-6, and 269.97)
have been sequenced, only three genomes of C. jejuni (305,
RM1221, and 81-176-DRH212) from poultry have been obtained
(Parkhill et al., 2000; Fouts et al., 2005; Hofreuter et al., 2006).
C. jejuni RM1221 (ATCC BAA-1032) is a chicken isolate with
unique lipoolgosaccharide and ability to colonize chicken skin
(Fouts et al., 2005). C. jejuni 305 is a turkey isolate with stress
tolerance (Takamiya et al., 2011). C. jejuni 81–176-DRH212
is a C. jejuni 81–176 variant with enhanced fitness in the
chicken gastrointestinal tract (Johnson et al., 2014). The genome
sequences of broiler C. jejuni isolates with multidrug resistance
and high virulence have not been published previously. In
order to investigate the mechanisms involved in the multidrug
resistance and increased virulence in C. jejuni isolated from
broiler chickens in China, the genomic profile of a C. jejuni
isolate with relative higher virulence and multidrug resistance
was determined by the de novo sequencing technology in the
present study.
MATERIALS AND METHODS
Isolation and Identification of Chicken
C. jejuni
Six strains (1442, 1447, 1614, 1622, 1655, and 1685) were isolated
from caecum of healthy broiler chicken in the chicken farms
located in the center of China in 2013. These farms have a long
history of usage of different antimicrobial drug for prevention
and treatment chicken disease. These strains were confirmed as
C. jejuni by classic biochemical test and PCR amplification of the
16S rRNA, mapA and vs1 genes (Stucki et al., 1995; Hao et al.,
2013, 2015). TheC. jejuni isolates were grown onMueller-Hinton
(MH) agar supplemented with 5% sheep blood at 42◦C under
microaerobic conditions (5% O2, 10% CO2, and 85% N2) for
24–48 h.
Antimicrobial Susceptibility Test
The minimum inhibitory concentrations (MICs) of
erythromycin (ERY), tylosin (TYL), ciprofloxacin (CIP),
enrofloxacin (ENR), doxycycline (DOX), tetracycline (TET),
amikacin (AMK), and gentamicin (GEN) were determined
using the agar dilution method as recommended by the Clinical
and Laboratory Standards Institute (CLSI) M31-A3 guidelines
(CLSI., 2008). The C. jejuni ATCC33560 was used as quality
control for the MIC determination.
Preliminary Pathogenicity Test
Newly hatched broiler chickens were purchased from Zhengda
Limited Company (Wuhan, China). Prior to the experiment,
all the chickens tested negative for C. jejuni strains by C.
jejuni isolation and identification methods. The chickens were
randomly divided into 8 groups with 7 chickens in each group.
The chickens in groups 1–7 were administrated once with 5× 105
CFU of each C. jejuni strain (1442, 1447, 1614, 1622, 1655, 1685,
and RM1221) by oral injection, respectively. The eight group
served as the negative control with no bacterial infection. The
clinical symptoms and mortality of the chickens in each group
was observed daily. The colonization rate of each C. jejuni strain
was determined using selective medium containing 32 αg/mL
erythromycin.
Cytotoxin Assay
Themurine macrophage RAW264.7 cell line was used to evaluate
the cytotoxic effects of the six C. jejuni isolates. The tissue culture
cytotoxin assay was carried out as previously described (Guerrant
et al., 1987) with some modification. Briefly, C. jejuni was treated
by 2000 µg/ml polymyxin B for 1 h at 37◦C (Ashkenazi and
Cleary, 1990) and centrifuged at 8000 rpm for 20min. The
supernatant were filtered through 0.22 µm filter. Purified shiga
toxin (Chinese Center for Disease Control and Prevention) and
0.3% Triton X-100-PBS were used as positive controls, and
polymyxin B-treated broth and polymyxin B-PBS (phosphate-
buffered saline) were used as negative controls. Suspensions of
murine macrophage RAW264.7 cells (100 µl; 5× 105 cells) were
placed in 96-well flat-bottom microtiter plates and allowed to
adhere for 1 to 3 h to form the tissue culture monolayers. Serial
twofold dilutions of the prepared C. jejuni filtrates were added to
the tissue culture monolayers in 100µl volumes. The monolayers
were incubated with the filtrates at 37◦C in 5% CO2 for 24 h. The
monolayers were then examined by phase-contrast microscopy
for the percentage of cells rounded. Cell death was determined
by trypan blue dye uptake (A540 value) and correlated with cell
morphology after Giemsa staining. The index of cytotoxin effect
was calculated by the formula.
100×
[
1−
A540(test)− A540(positive)
A540(negative)− A540(positive)
]
.
Biofilm Assays
To measure the biofilm formation of the six C. jejuni strains,
crystal violet staining was used as described previously for
C. jejuni and other bacteria (Asakura et al., 2007; Fields and
Thompson, 2008; McLennan et al., 2008; Reuter et al., 2010) with
some modification. Briefly, the 200 αl of C. jejuni fresh culture
(OD600 = 0.05) was added to 96-well flat-bottom microtiter
plates. Plates were incubated without shaking at 42◦C under
microaerobic conditions for 24, 48, and 72 h. For crystal violet
staining, each well was washed with PBS three times to remove
the planktonic cells. The 200 αl of methanol were added and
incubated for 15 min and then dried at room temperature. Then
200 αl of 0.1% Hucker crystal violet solution were added, and the
plates were incubated at room temperature for 5 min. Unbound
crystal violet was washed off with PBS, and the plates were dried
at 60◦C. Bound crystal violet was dissolved in 30% glacial acetic
acid for 10 min. The absorbance was determined using a plate
reader at 570 nm. The wells with sterile medium were used as
blank control. The blank corrected absorbance values of C. jejuni
strains were used for reporting biofilm production. Assays were
repeated at least three times with three technical replicates.
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LD50 Determination
Based on the results from the preliminary pathogenicity
experiments with chickens, cytotoxin testing and biofilm assays,
three C. jejuni isolates (1442, 1622, and 1655) were selected
to further determine their median lethal dose (LD50) using 2
days old chicken orally or intraperitoneally infected with a range
of concentration (105–107 CFU) of each C. jejuni isolate. All
the chickens tested negative for C. jejuni prior to inoculation
using the C. jejuni isolation and identification methods described
above. The chickens were randomly divided into six groups
with 35 chickens in each group. The chickens in each group
were orally or intraperitoneally administrated with 0, 105,
106, or 107 CFU of the C. jejuni isolates, respectively. Seven
chickens were inoculated with each of the dilution of the test
strains.
Adhesion and Invasion Assay
The adhesion and invasion of these three C. jejuni strains
(1442, 1622, and 1655) was determined as previously described
(Almofti et al., 2011a). Briefly, 5.0 × 107 CFU/mL of the
C. jejuni strain was used to inoculated the monolayers of
macrophage RAW264.7 cells at multiplicity of infection (MOI)
of 100. The infected monolayers were incubated for 3 h to allow
the occurrence of adhesion and invasion. For determination
of the total number of adherent and internalized bacteria, the
monolayers were washed three times with Dulbecco’s Modified
Eagle’s Medium (DMEM) without antibiotic to remove the
extracellular unbound bacteria. The monolayers were then lysed
to release the intracellular bacteria. For determination of the
invading bacteria, the monolayers were washed twice with
aspirated DMEM medium and 100 mg/ml gentamicin was
added for 1 h to kill the extracellular and bound bacteria.
The monolayers were then washed three times and lysed
to release intracellular bacteria. The number of adherent
bacteria was obtained by subtraction of the internalized bacteria
number from total number of adherent and internalized
bacteria.
Intracellular Survivability Assay
To determine the intracellular survivability of C. jejuni within
macrophage RAW264.7, the invasion period of each C. jejuni
strain (1442, 1622, and 1655) was extended to 3, 6, 10, 16, 24,
48, and 72 h post-infection. Cells were washed and lysed as
previously described in the adhesion and invasion assay. The
surviving intracellular bacteria were enumerated by plating serial
dilutions on blood agar and counting the resultant colonies.
Motility Test
To determine the migration of the three selected strains (1442,
1622, and 1655), a fresh culture of C. jejuni strain was inoculated
into MH broth and cultured to their logarithmic growth phase.
Then 3 αl of bacteria with consistent concentration were stabbed
into 0.4 % MH agar. Plates were incubated at 42◦C under
microaerophilic conditions for 24 h and the motility was scored
by measuring the diameter of the growth in each plate. The
experiment was performed in triplicate.
De NovoWhole-Genome Sequencing Of
C. jejuni 1655
Total genomic DNA of C. jejuni 1655 was extracted using the
TIANamp Bacteria DNA kit according to the manufacturer’s
protocol. The genomic DNA was sent to Shanghai Biotechnology
Corporation for the de novo whole genome sequencing
performed in a HiSeq 2500 platform using a multiplexed, 2 ×
100 nucleotide paired end approach (Illumina). The sequence
analysis and assembly were carried out using CLC Genomics
Workbench (ver. 6.0., Qiagen). Prediction and identification of
the main components of the genome, including open reading
frames (ORFs), tRNA, rRNA, ncRNA, CRISPR-Cas system, and
repeat elements, were conducted using software of Glimmer 3.02
and some other online tools.
The nucleotides and predicted proteins of 1655 were
compared with previously sequenced C. jejuni genomes in
GenBank using updated nt and nr databases with BLAST
software. The genomes used as reference sequences for the
comparative genomic analysis were C. jejuni 81–176, C. jejuni
NCTC11168, C. jejuni RM1221. The comparative genomic
analysis was performed using BLASTN, BLASTX, Mummer and
Quast. The sequence data from C. jejuni 1655 was compared to
the results of antimicrobial resistance and virulence to identify
genetic factors that correspond to the observed mechanisms.
Nucleotide Sequence Accession Numbers
The whole genome sequence of C. jejuni 1655 has been deposited
at DDBJ/ENA/GenBank under the accession MDDM00000000.
Ethics Statement
All the experimental procedure in this study was performed
according to the guidelines of the committee on the use and care
of the laboratory animals inHubei province China. The study was
approved by Animal Ethics Committee of HuazhongAgricultural
University (hzauch 2014-002) and the Animal Care Center,
Hubei Science and Technology Agency in China (SYXK 2013–
0044). These experiments were in line with national regulations
about animal welfare ethics. All the animals were monitored
throughout the study for any adverse effect signs. All efforts were
made to minimize suffering of animals.
RESULTS
Minimum Inhibitory Concentration (MIC)
The minimum inhibitory concentrations (MICs) of different
antimicrobial agents against the 6 C. jejuni isolates (1442,
1447, 1614, 1622, 1655, and 1685) were presented in Table 1.
Each isolate exhibited resistance to all the tested drugs, while
three (1622, 1655, and 1685) showed higher-level MICs to
erythromycin and gentamicin than the others.
Pathogenicity of C. jejuni Isolates on
Chicken
After oral infection with 105 CFU of the C. jejuni isolates, no
clinical change was observed in two groups infected with 1442 or
1447, while the other four isolates (1614, 1622, 1655, and 1685)
and RM1221 caused different degrees of diarrhea and bloody
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TABLE 1 | MICs of different antimicrobial agents against six C. jejuni isolates (µg/mL).
Strains MICs of different antimicrobial agents
ERY TYL ENR CIP TET DOX GEN AMK
1442 128 >256 64 128 128 32 64 16
1447 64 >256 32 8 128 32 1 8
1614 256 >256 0.25 16 64 64 >256 4
1622 512 >256 256 128 >256 32 >256 64
1655 512 >256 32 64 256 32 >256 8
1685 512 >256 16 32 64 32 >256 16
RM1221 0.5 2.0 0.5 0.125 0.5 0.25 0.5 0.5
ERY, Erythromycin; TYL, Tylosin; ENR, Enrofloxacin; CIP, Ciprofloxacin; TET, tetracycline; DOX, Doxycycline; GEN, Gentamicin; AMK, Amikacin.
FIGURE 1 | Colonization change of C. jejuni isolates in chicken after inoculation. The Y-axis is the number (Log10 CFU/kg fece) of each strain colonizing the
birds at different days. The asterisk (*) and (**) represent statistical significant difference with P ≤ 0.05 and P ≤ 0.01 comparing with C. jejuni RM1221, respectively.
stools, respectively. The clinical signs of three strains (1614, 1685,
and RM 1221) were recovered at day 4, while serious diarrhea
caused by 1622 and 1655 was sustained for over 8 and 10 days,
respectively (Table S1). Therefore, 1655 exhibited relative higher
pathogenicity on chickens than RM1221 and other five C. jejuni
isolates. Within 15 days, the mortality of all the strains was 0%
following oral inoculation of 2 days-old chicken.
Colonization of C. jejuni Isolates in Chicken
After oral administration with 5 × 105 CFU of the C. jejuni
isolates to 2-days old chickens, all the strains could colonize
chickens’ intestinal tract. Fecal samples were obtained at different
time points (2, 4, 6, 8, and 10 days). RM1221 colonized at
concentration of 105–107CFU/kg feces at day 2 and day 4, but the
concentration was reduced to less than 104 CFU/feces at day 10
(Figure 1). The concentrations of five isolates (1442, 1447, 1622,
1655, and 1685) were higher than 104 CFU/kg feces within the ten
days (Figure 1). Comparing with the colonization of RM1221,
three isolates (1622, 1655, and 1685) exhibited significantly
stronger colonization (Figure 1).
Cytotoxin of the Six C. jejuni Isolates in
Macrophage Cells
Figure 2 showed the killing effect (index) of cytotoxin released
by six strains (1442, 1447, 1614, 1622, 1655, and 1685) on murine
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FIGURE 2 | Cytotoxic production of C. jejuni isolates in murine macrophage RAW264.7 cell. The Y-axis is the index of cytotoxic production of each strain.
The results were obtained from three independent repeats. The asterisk (*) and (**) represent statistical significant difference with P ≤ 0.05 and P ≤ 0.01 comparing
with C. jejuni RM1221, respectively.
FIGURE 3 | Biofilm formation of C. jejuni isolates at different time points under ordinary conditions. The Y-axis is the OD570 value of crystal violet in biofilm.
The results were obtained from three independent experiments. The asterisk (*) and (**) represent statistical significant difference with P ≤ 0.05 and P ≤ 0.01
comparing with C. jejuni RM1221, respectively.
macrophage RAW264.7. The killing effect of cytotoxin from all
the strains was lower than 80%. However, compared to RM 1221,
significant differences of the index of cytotoxin were observed in
theseC. jejuni strains. Among them, 1442, 1622, and 1655 seemed
to release more cytotoxin and therefore exhibited higher killing
effect on murine macrophage RAW264.7.
Biofilm Formation of the Six C. jejuni
Isolates
Different level of biofilm formation was observed in eachC. jejuni
strain (Figure 3). It seemed that the level of biofilm formation
had positive correlation with the incubation time. The highest
level of biofilm formation was occurred after 72 h incubation
(Figure 3). Compared to RM1221, a significant difference of
biofilm formation was observed in three isolates (1614, 1655,
and 1685) after each incubation time, indicating that these three
strains may have stronger ability to form biofilm (Figure 3).
LD50 of the Three Selected C. jejuni
Isolates on Chicken
From the preliminary pathogenicity testing on chicken, cytotoxin
testing and biofilm assays, three isolates (1442, 1622, and 1655)
were selected for LD50determination. As the result shown in
Table 2, different fatality rates were observed in different groups.
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After oral infection, the highest concentration (3.70 × 107 CFU)
of 1442 and 1622 could causemortality rate of 0% (0/7) and 28.6%
(2/7) respectively, while 3.7× 107 CFU of 1655 cause fatality rate
of 55.6% (4/7). For intraperitoneal infection, 3.7 × 106CFU of
1442 and 1622 only leaded to one chicken death, while the lowest
concentration (3.7×105 CFU) of 1655 leaded to 100% death of
chickens. The 1655 exhibited highest pathogenicity on chicken
with the calculated LD50 of 8.45 × 10
7 CFU for oral infection
and LD50 of less than 3.7× 10
5 CFU for Intraperitoneal infection
(Table 2).
Adhesion and Invasion of C. jejuni on
Macrophage RAW264.7
The three isolates (1442, 1622, and 1655) exhibited remarkable
higher adhesion and invasion to macrophage cell RAW264.7
than RM1221 (Figure 4). The significant change of adhesion to
macrophage cells (P < 0.01) was observed in 1622 and 1655.
However, there was no significant difference in the adhesion and
invasion between three selected isolates (1442, 1622, and 1655).
Intracellular Survivability of C. jejuni in
Macrophage RAW264.7
The intracellular survivability of the three strains (1442,
1622, and 1655) was shown in Figure 5. Comparing with
RM1221, three selected strains showed remarkable advantage in
intracellular survivability in murine macrophage RAW 264.7.
RM1221 had short survival time (24 h), while three strains were
able to survive for more than 48 h, although a considerable
decrease in the number of all internalized was observed. Among
them, 1622 and 1655 exhibited highest survivability at 72 h. At
each time point, the post-infection number of surviving 1655
was higher than 1622, suggesting that 1655 strain had strongest
survivability.
Motility of the Three Selected C. jejuni
As shown in Figure 6, there was apparent difference between
diameter growth rings of the three strains (1442, 1622, and 1655)
on 0.4%MH agar plate. RM1221 and 1622 were not motile, while
1655 and 1442 had a strong motility.
Whole-Genome Features of C. jejuni 1655
Based on the above in vitro and in vivo studies, 1655 was selected
for subsequent whole genome sequencing to analyze the potential
genetic mechanisms involved in the multidrug resistance and
high virulence.
The basic genome information of 1655 and other three
reference strains (RM1221, 81–176, and NCTC11168) are
summarized into Table 3. The 1655 genome was comprised of
a chromosome and a tetracycline resistance plasmid pTet. The
pTet plasmid of 1655 had 98% homology with pTet plasmid in
81176. The genome of 1655 was 1720, 061 bp long and contained
1733 predicted coding regions. The genomes of two chicken
original strains (1655 and RM1221) were significantly larger than
that of two human isolates (C. 81–176 and NCTC11168). The
GC content of 1655 was 31.36%, consistent with the reference
genome sequences.
TABLE 2 | LD50 of the three multidrug resistant strains on 2 days old
chickens.
Infection
route
Strains Infection
dose of
(CFU)
Number
of
chickens
Number
of Dead
chicken
LD50
Oral infection 1442 3.70 × 107 7 0 NA
3.70 × 106 7 0
3.70 × 105 7 0
0 7 0
1622 3.70 × 107 7 2 NA
3.70 × 106 7 0
3.70 × 105 7 0
0 7 0
1655 3.70 × 107 7 4 8.45 × 107
3.70 × 106 7 1
3.70 × 105 7 1
0 7 0
Intraperitoneal
infection
1442 3.70 × 107 7 2 NA
3.70 × 106 7 1
3.70 × 105 7 0
0 7 0
1622 3.70 × 107 7 1 NA
3.70 × 106 7 1
3.70 × 105 7 0
0 7 0
1655 3.70 × 107 7 7 <3.70 × 105
3.70 × 106 7 7
3.70 × 105 7 7
0 7 0
The genome sequence of 1655 was composed by 35 large
contigs (Figure 7). The cluster of orthologous groups (COG)
assignment for predicted gene products were shown in the third
circle from the outside in Figure 7. A total of 1733 putative gene
products were assigned to COG identifications classified into 19
COG categories. Three copies of rRNA gene cluster (5s rRNA, 16s
rRNA, and 23s rRNA) and 40 tRNA genes were identified on the
C. jejuni 1655 chromosome.
The global alignment of four genomes (RM1221, 81–176,
NCTC11168, and 1655) is shown in Figure 8. High similarity
was observed in the genome of three reference strains (RM1221,
81–176, and NCTC11168). However, disordered distribution,
deletions and rearrangements were observed in the genome of
1655 when compared with genome of three reference strains.
Resistance Determinants in C. jejuni 1655
The genome sequencing data showed that 1655 contained T86I
mutation in the gyrA gene. Some mutations (e.g., A2075G
mutation, C2113T, position 1732–1791 mutations) were found
in the 23S rRNA of C. jejuni 1655. The ribosomal L4 contained
V196A mutation and ribosomal L22 had A74G mutation. The
tetracycline resistant gene tetO was located in pTet plasmid. The
C. jejuni 1655 also contained aphA and aadE exogenous genes
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FIGURE 4 | Adhesion (left) and invasion (right) of C. jejuni strains in macrophage RAW264.7 cell. The Y-axis is the mean of log10 CFU/mL of each strain in
the cells. The results were obtained from three independent experiments. The asterisk (*) and (**) represent statistical significant difference with P ≤ 0.05 and P ≤ 0.01
comparing with C. jejuni RM1221, respectively.
FIGURE 5 | Intra-macrophage survival assay of three selected C. jejuni strains in macrophage RAW264.7 cell. The Y-axis is the mean of log10 CFU/mL of
each strain in the cell. The asterisk (*) and (**) represent statistical significant difference with P ≤ 0.05 and P ≤ 0.01 comparing with C. jejuni RM1221, respectively.
which mediated resistance to aminoglycosides. No mutation wad
found in the regulators (CmeR and CosR) of CmeABC eﬄux
pumps.
Virulence Associated Genes in C. jejuni
1655
A large number of virulence associated genes were found
in the genome of 1655 (Table 4). Among the selected genes
involved in flagella synthesis and assembly (flaA, flaC, flgA,
flgB, flhB, fliM, and fliY), the flaC was found in the genome
of 1655 and 11168. Two genes (ciaB and nlpC) associated
with invasion and three genes (cadF, galE, and peb2) related to
adhesion were present in 1655 but not in RM1221. Compared
to the genes of CPS biosynthesis system in RM1221, the
genome of 1655 contained a restriction modification enzyme,
sugar nucleotidyltransferase, capsule polysaccharide protein,
and alginate O-acetyltransferase. The genome of 1655 also
contained some genes (cfrA and ExbB-ExbD-TonB) involved
Frontiers in Microbiology | www.frontiersin.org 7 October 2016 | Volume 7 | Article 1605
Hao et al. Genome of Virulent Campylobacter Strain
FIGURE 6 | Motility of the three selected C. jejuni strains on 0.4% MH
plate. The motility is positively corrleated to the diameter of growth ring of
each strain. The diameter of spotted colonies was 0.5 cm.
in iron uptake system, while RM1221 lacked TonB and 81176
lacked cfrA and TonB13. The IS606 transposase, ISHa1675
transposase B and prophage Lp2 protein 6 were also found in
the genome of 1655. ISHa1675 transposase B was not found
in the genome of three reference strains. The sequence of
prophage Lp2 protein in C. jejuni 1655 had 99% homology
to that in 81–176. The pVir plasmid which previously found
in 81–176, was not found in 1655. Three predicted genes
of Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR)-associated system were found in the genome of
1655. They may encode Csn1, Cas1, and Cas2 proteins
respectively.
DISCUSSION
Compared to the genomes of reference strains (NCTC11168,
81–176, RM1221), the genome of 1655 contained some gene
inversion, disordered distribution, deletions and rearrangements.
The genome difference may be attributed to their different
biological characteristics and different evolutional environment.
NCTC11168 was originally isolated from a case of human
enteritis (Parkhill et al., 2000). 81–176 was originally isolated
from a diarrheal outbreak associated with raw milk consumption
and exhibited high invasion and high pathogenicity for
monkeys and humans (Korlath et al., 1985; Black et al.,
1988; Tribble et al., 2010). C. jejuni RM1221 (ATCC BAA-
1032) was isolated from chicken and showed low virulence
(Fouts et al., 2005). 1655 was a multidrug resistant strain
TABLE 3 | Genomic information of target bacteria 1655 and reference
strains.
Genomic
contents
1655 NCTC11168 RM1221 81–176
Refseq number NC_002163.1 NC_003912.7 NC_008787
Homology (%) – 88.78 90 90.44
Genome size
(bp)
1720061 1641481 1777831 1616554
G+C (%) 31.36 30.5 30.31 30.6
Predicted coding
region
1733 – 1898 1770
CDS 1732 1668 1783 1680
Proteins – 1572 1783 1449
Pseudo gene 323 40 58 35
rRNA 9 9 9 9
tRNA 40 43 44 44
Other RNA 326 4 4 2
isolated from chicken fecal samples that exhibited relative
higher virulence, as evidence by its higher pathogenicity to
chickens, colonization of the chicken intestinal tract, cytotoxin
production, biofilm formation, adhesion/invasion/intracellular
survivability to macrophage cell and higher
motility.
1655 had multidrug resistance to fluoroquinolones,
macrolides, tetracyclines and aminoglycosides. The single T86I
mutation in gyrA gene contributed to its high-level resistance
to FQs (Luangtongkum et al., 2009). High level macrolide
resistance in C. jejuni 1655 was likely due to A2075G mutation
in 23S rRNA (Hao et al., 2009; Luangtongkum et al., 2009; Hao
et al., 2010). Although there were some other mutations and
deletions in gyrB, 23s rRNA genes and ribosomal L4/L22, the
function of these mutations on antimicrobial resistance was not
evident. The high-level resistance to tetracycline was mediated
by tetO gene which was located in pTet plasmid (Avrain et al.,
2004). The pTet plasmid in 1655 was identical to the one found
in 81–176 (Bacon et al., 2002). As a mobile gene element, pTet
plasmid may act as a vehicle to pick up and spread multiple
antibiotic resistance genes and virulence genes in C. jejuni (chen
et al., 2013). The aadE and aphA-3 genes in 1655 could explain
its resistance to amikacin and gentamicin (Gibreel et al., 2004;
Iovine, 2013).
Generally it has been through that multidrug resistance
is often associated with higher fitness costs or less virulence
(Luangtongkum et al., 2009). However, our study suggested
that the multidrug resistant 1655 had higher virulence than
the reference strain RM1221 that is not multidrug resistant.
Previous studies indicated that T86I mutation in gyrA gene
could affect DNA supercoiling to regulate the expression of
genes associated with bacterial fitness, and therefore enhance
the fitness of fluoroquinolone-resistantCampylobacter in chicken
host and increase the severity and duration of Campylobacterosis
(Nelson et al., 2004; Luo et al., 2005; Helms et al., 2005;
Evans et al., 2009; Han et al., 2012). However, mutations in
23S rRNA could lead to fitness cost and reduced virulence of
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FIGURE 7 | Schematic circular genome of C. jejuni 1655 strain. From outside to inside, there were five rings. The first circle shows the positive strand genes.
The second circle shows the negative strand genes. The third circle were COG functional annotations (chr1-RNA processing and modification; chr2-Chromatin
structure and dynamics; chr3-Energy production and conversion; chr4-Cell cycle control, cell division, chromosome partitioning; chr5-Amino acid transport and
metabolism; chr6-Nucleotide transport and metabolism; chr7-Carbohydrate transport and metabolism; chr8-Coenzyme transport and metabolism; chr9-Lipid
transport and metabolism; chr10-Translation, ribosomal structure and biogenesis; chr11-Transcription; chr12-Replication, recombination and repair; chr13- Cell
wall/membrane/envelope biogenesis; chr14-Cell motility; chr15-Posttranslational modification, protein turnover, chaperones; chr16-Inorganic ion transport and
metabolism; chr17-Secondary metabolites biosynthesis, transport and catabolism; chr18-General function prediction only; chr19-Signal transduction mechanisms).
The fourth circle are rRNA and tRNA (red-16s rRNA, blue-23S rRNA, yellow-5S rRNA, black-positive chain tRNA, green-negative chain tRNA). The fifth circle is the GC
contents.
macrolide resistant Campylobacter (Hao et al., 2009; Almofti
et al., 2011a,b; Hao et al., 2013). Some of the clinical
investigation data indicated the positive correlation between
virulence and resistance, but others indicated the negative
correlation (Bagger-Skjøt et al., 2007; McGowan-Spicer et al.,
2008). For example, two recent studies showed that prevalence
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FIGURE 8 | Global multiple alignment of C. jejuni genomes. From top to bottom are the genome structures of C. jejuni RM1221, 81–176, NCTC11168, and
1655, respectively. The color region and white region represented high and low similarity respectively. Above axis was the positive strand, below was the negative
strand.
of resistance to both erythromycin and ciprofloxacin was higher
in isolates harboring ciaB and some virulence genes (e.g.,
cdtA and dnaJ) were associated with antimicrobial-resistant
Campylobacter strains (Ghunaim et al., 2015; Lapierre et al.,
2016). Our study revealed the relationship between multidrug-
resistance and virulence of some C. jejuni chicken isolates,
indicating that complex mechanisms may work together to cause
multidrug resistance and the relative higher virulence in C. jejuni
1655.
Comparing to the genome of RM1221, 1655 contained some
special virulence-associated genes and proteins, including flaC,
ciaB, nlpC, cadF, gelE, peb2, restriction modification enzyme,
sugar nucleotidyltransferase, capsule polysaccharide protein,
alginate O-acetyltransferase and TonB iron uptake system. The
flaC has been shown to modulate immune response in the
intestinal tract and contribute to bacterial persistence of C. jejuni
(Faber et al., 2015). The presence of ciaB, a Campylobacter
invasion antigen, may contribute to the high invasion of C.
jejuni 1655 (Rivera-Amill and Konkel, 1999). The nlpC may
play a critical role in initial infection process, adherence to
host cells (Padhi et al., 2016). The cadF, encoding fibronectin
protein, may play an important role on the adhesion and
colonization of 1655 in chicken (Konkel et al., 1997; Monteville
et al., 2003). The peb2 is a membrane associated protein which
may contribute to the increased gastrointestinal virulence of
C. jejuni (Cordwell et al., 2008). The capsule polysaccharide
(CPS), lipooligosaccharide (LOS), and restriction-modification
(R/M) systems may enhance the invasion and colonization of
1655 in reservoir hosts and mediate the virulence of 1655 by
evading host immune response (Bacon et al., 2001; Suerbaum
et al., 2001; Ahmed et al., 2002; Guerry et al., 2002; Klena
et al., 2004; Poly et al., 2004; Fouts et al., 2005; Guerry and
Szymanski, 2008). The outer membrane protein CfrA and
energy transporter system TonB-ExbB-ExbD are associated with
iron absorption and iron uptake in gram-negative bacteria
(Krewulak and Vogel, 2011). The presence of CfrA and TonB-
ExbB-ExbD system in 1655 may contribute to its stronger
ability of nutrients uptake and higher intracellular survivability
(Andrews et al., 2003; Hofreuter et al., 2006; Krewulak and Vogel,
2011).
The genes encoding IS606 transposase, ISHa1675 transposase
B and prophage Lp2 protein 6 were identified in the genome of
1655, suggesting that 1655 may contain transposons or phages.
However, future experiments are needed to determine if these
are associated with active mobile genetic elements in 1655. The
ISHa1675 transposase B and prophage Lp2 protein 6 were not
found in the genome of RM1221 and 11168, indicating that these
two genes may play special role in the physiological characteristic
of C. jejuni 1655.
Three proteins associated with CRISPR-Cas systems
(CRISPR-Cas2, CRISPR-Cas1 and a hypothetical protein
associated with the CRISPR) were found in 1655. The CRISPR-
Cas system provides bacterial defense against foreign nucleic
acids derived from bacteriophages or plasmids (Barrangou
et al., 2007; Marraffini, 2013). It also plays an important role in
gene regulation and bacterial pathogenicity (Mojica et al., 2005;
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TABLE 4 | Virulence relative factors in C. jejuni 1655 and reference strains.
Virulence genes 1655 1221 11168 81176
Virulence Relative high No Low Intermediate
pVir Plasmid − − − +
FLAGELLA SYNTHESIS GENES
flaA + + + +
flaC + − + −
flhB + + + +
flgB + + + +
fliM + + + +
fliY + + + +
INVASION
ciaB + − + −
nlpC + − − +
ADHESION
cadF + − + −
galE + − − −
Peb1 + + + +
Peb2 + − + −
CHEMOTAXIS
cheY + + + +
motB + + + +
dnaJ + + + +
CPS BIOSYNTHESIS SYSTEM
Restriction modification enzyme + − + −
LPS biosynthesis protein − + − +
Sugar nucleotidyltransferase (CPS) + − + +
Capsule polysaccharide protein (KPS) + − + −
Alginate O-acetyltransferase AlgI + − − −
IRON UPTAKE SYSTEM
cfrA + + + −
TonB123 + − + −
ExbB + + + +
ExbD + + + +
TRANSPOSASE AND PHAGES PROTEINS
IS606 transposase + + + −
ISHa1675 transposase B + − − −
Prophage Lp2 protein 6 + − − +
CRISPR-CAS SYSTEM
CRISPR csn1-cas1-cas2 csn1-cas1-cas2 csn1-cas1-cas2-CRISPR-cstIII cstII
Louwen et al., 2013; Louwen and van Baarlen, 2013; Sampson
and Weiss, 2014). Strains containing CRISPR-Cas system have a
stronger ability of biofilm formation and colonization in mouse
organs than those strains lack this system (Shimomura et al.,
2011). Therefore, the presence of CRISPR-Cas system may
contribute to the high virulence and biofilm formation capacity
of C. jejuni 1655 strain.
CONCLUSION
1655 strain exhibited multidrug resistance to fluoroquinolone,
macrolide, tetracycline, and aminoglycoside drugs and relative
high in vitro and in vivo virulence. Comparing to the
genome of reference strains (NCTC11168, RM1221, and
81–176), there were large difference in the genome structure
and genome content in 1655. The co-emergence of target
gene mutations, resistance genes and pTet plasmid could
explain its multidrug resistance. The virulence mechanism of
Campylobacter may be mediated by a variety of virulence
factors, including proteins involved in flagella biosynthesis,
invasion, adhesion, CPS biosynthesis system, iron uptake
system, transposase, phage proteins, and CRISPR-Cas system.
Future experiments are needed to find the deeper molecular
mechanisms and confirm the function of some important
gene elements on multidrug resistance and relative higher
virulence.
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